MG Pharma Representative Yasuo Sumida (Rohto Pharmaceutical Group) to Appear on Radio NIKKEI's 'BIZ&TECH TERMINAL'

MG Pharma Representative Yasuo Sumida will appear on Radio NIKKEI No. 1's program 'BIZ&TECH TERMINAL'. Broadcasting on May 19 and 26, the program will cover ectopic fat, the proprietary material 'Metap', and the company's initiatives.
イベントNQ 71/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 19, 2026 at 00:30
  • 🔍 Collected: May 18, 2026 at 16:01
  • 🤖 AI Analyzed: May 18, 2026 at 17:21 (1h 20m after Collected)
Our Representative, Yasuo Sumida, will make an appearance on Radio NIKKEI No. 1's program 'BIZ&TECH TERMINAL'.

During this appearance, we plan to broadly introduce topics ranging from simple questions like 'What is ectopic fat?' and 'What kind of material is Metap?' to our company's initiatives and future developments.

Please tune in.

■ Program Overview

Program Name: 'SWITCH ON THE NEXT' corner within 'BIZ&TECH TERMINAL'

Personality: Kantokun Hara (Mr. Toshihiko Hara)

Broadcast Date and Time: Part 1 - Tuesday, May 19, 2026, from past 22:15
Part 2 - Tuesday, May 26, 2026, from past 22:15

Broadcasting Station: Radio NIKKEI No. 1 Official Site: https://www.radionikkei.jp/btt/

■ About Ectopic Fat

When speaking of fat, subcutaneous fat and visceral fat are common, but ectopic fat, also called the 'third fat,' is fat that accumulates in organs where it should not normally be, such as the muscles, liver, heart, and pancreas.

It has been pointed out to be related to various diseases that plague modern people, such as frailty, sarcopenia, infertility, depression, and dementia, and is attracting attention as a future social issue related to healthy life expectancy.

MG Pharma operates the project 'Team Ectopic Fat by MGP' to promote research and information dissemination approaching this ectopic fat.

Team Ectopic Fat by MGP: https://ishosei-shibou.com

Instagram: https://www.instagram.com/ishoseishibou_teamofficial/

■ About MG Pharma's Proprietary Material 'Metap®'

'Metap® (globin digest)', a peptide mixture and proprietary material created from over 30 years of research by MG Pharma, has the functionality to suppress the rise in serum neutral fat after meals by approximately 60%, and was incorporated into Japan's first FOSHU (Food for Specified Health Uses) for neutral fat, 'Napple® Drink', in 1999.

Currently, we are advancing research on its approach to ectopic fat as a new possibility for Metap®, and the value of the material is expanding from countermeasures against neutral fat to countermeasures against ectopic fat.

Napple® Drink Food for Specified Health Uses

[MG Pharma Inc. Company Profile]

Supporting health and contributing to the happiness that lies beyond.

Company Name: MG Pharma Inc. (Rohto Pharmaceutical Group)
Representative: Representative Director Yasuo Sumida
Location: 7-7-25 Saitoasagi, Ibaraki City, Osaka Prefecture
Founded: November 13, 1969
URL: https://www.mgpharma.co.jp/

FAQ

Which radio program will Yasuo Sumida appear on?

Radio NIKKEI No. 1's 'BIZ&TECH TERMINAL', broadcasting on May 19 and 26, 2026.

How does ectopic fat affect health?

It accumulates in organs where it shouldn't, and is linked to diseases like frailty, sarcopenia, and dementia.

What kind of material is Metap?

A peptide mixture researched by MG Pharma for over 30 years, shown to suppress neutral fat rise by about 60%.